Literature DB >> 11807441

Economic analysis in dermatology.

Charles N Ellis1, Kristin L Reiter, John R C Wheeler, A Mark Fendrick.   

Abstract

Cost-effectiveness studies are rising in importance as means for justifying expenditures on health interventions and as guides for making treatment and resource allocation decisions. However, the term "cost-effective" often is used erroneously, attributed to therapies that have not been subjected to rigorous cost analysis or comparison to an appropriate alternative. Health economic studies include cost-of-illness, cost-minimization, cost-effectiveness, cost-utility, and cost-benefit analyses. Each of these types of analyses differs in what it measures and under what circumstances its use is appropriate. This article describes the different types of economic studies, using examples to highlight their key features, and provides a summary of the key components of an economic analysis including perspective, cost and outcomes measurement, time horizon, cost-discounting, and sensitivity analysis.

Mesh:

Year:  2002        PMID: 11807441     DOI: 10.1067/mjd.2002.119566

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  [Health economics studies in dermatology].

Authors:  C Rogalski; J Simon; U Paasch
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

Review 2.  The economics of topical immunomodulators for the treatment of atopic dermatitis.

Authors:  William Abramovits; Mark Boguniewicz; Amy S Paller; Diane L Whitaker-Worth; Mary M Prendergast; Michael Tokar; Kuo B Tong
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Evaluation of the quality and cost-effectiveness of Versajet hydrosurgery.

Authors:  David C G Sainsbury
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

4.  Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.

Authors:  Adrienn Katalin Poór; Fanni Rencz; Valentin Brodszky; László Gulácsi; Zsuzsanna Beretzky; Bernadett Hidvégi; Péter Holló; Sarolta Kárpáti; Márta Péntek
Journal:  Qual Life Res       Date:  2017-09-05       Impact factor: 4.147

5.  Factors Influencing the Total Inpatient Pharmacy Cost at a Tertiary Hospital in Malaysia: A Retrospective Study.

Authors:  Syed Mohamed Aljunid; Saad Ahmed Ali Jadoo
Journal:  Inquiry       Date:  2018 Jan-Dec       Impact factor: 1.730

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.